疏血通治疗急性脑梗死疗效观察  

Clinical effect observation of Shuxuetong injection in the treatment of acute ischemic stroke

作　　者：关亚云[1] 

机构地区：[1]中国人民武装警察部队学院医院,河北廊坊065000

出　　处：《中国医药科学》2013年第11期78-79,共2页China Medicine And Pharmacy

摘　　要：目的观察疏血通治疗急性脑梗死的疗效。方法将120例急性脑梗死患者随机分为治疗组和对照组各60例,治疗组予以疏血通6mL;对照组川芎嗪120mg,均每日1次,用药14d,依据1995年全国第四届脑血管病会议通过的脑卒中患者临床神经功能缺损程度评分标准对两组治疗前后进行评分。结果治疗14d后治疗组的患者临床神经功能缺损程度评分较对照组明显降低,差异有统计学意义(P<0.01)。结论疏血通注射液治疗急性脑梗死安全有效。Objective To observe the clinical effection of Shuxuetong injection in the treatment of acute ischemic stroke. Methods 120 cases of patients with acute ischemic stroke were divided into 60 cases of the treatment group and control group randomly. The treatment group was given Shuxuetong injection 6 mL. Control group were given ligustrazine injection 120 mg, intrvenous infusion once a day, a total of 14 days. Score the clinical effection of the two groups before and after treatment according to the grading standard of clinical neurological impairment from the Fourth National Conference on cerebrovascular diseases in 1995. Results After 14 days of treatment, the neurologic impairment evaluation score of the treatment group is significant lower than the control group（P 〈 0.01）. Conclusion Shuxuetonz iniection is safe and reliable in treatinz acute ischemic stroke.

关 键 词：疏血通注射液 脑梗死 疗效观察 

分 类 号：R743.1[医药卫生—神经病学与精神病学]